Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$2.2 - $4.98 $5,478 - $12,400
2,490 Added 122.54%
4,522 $10,000
Q1 2024

May 14, 2024

BUY
$2.1 - $4.83 $1,287 - $2,960
613 Added 43.2%
2,032 $8,000
Q4 2023

Jan 31, 2024

SELL
$1.12 - $3.73 $2,077 - $6,919
-1,855 Reduced 56.66%
1,419 $4,000
Q3 2023

Nov 13, 2023

BUY
$1.22 - $2.67 $3,994 - $8,741
3,274 New
3,274 $4,000
Q2 2022

Aug 15, 2022

BUY
$4.04 - $8.51 $565,082 - $1.19 Million
139,872 Added 353.21%
179,472 $887,000
Q1 2022

May 13, 2022

BUY
$7.6 - $11.02 $99,438 - $144,185
13,084 Added 49.34%
39,600 $301,000
Q4 2021

Feb 14, 2022

SELL
$10.16 - $16.17 $341,548 - $543,586
-33,617 Reduced 55.9%
26,516 $271,000
Q3 2021

Nov 15, 2021

BUY
$13.16 - $22.47 $791,350 - $1.35 Million
60,133 New
60,133 $807,000
Q1 2021

May 13, 2021

SELL
$17.58 - $32.59 $442,805 - $820,876
-25,188 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$10.99 - $20.4 $4.37 Million - $8.12 Million
-398,023 Reduced 94.05%
25,188 $453,000
Q3 2020

Nov 12, 2020

BUY
$11.55 - $23.75 $2.7 Million - $5.56 Million
234,045 Added 123.72%
423,211 $4.89 Million
Q2 2020

Aug 13, 2020

BUY
$9.57 - $24.37 $1.35 Million - $3.44 Million
141,296 Added 295.17%
189,166 $4.59 Million
Q1 2020

May 13, 2020

BUY
$9.07 - $26.32 $434,180 - $1.26 Million
47,870 New
47,870 $528,000
Q4 2019

Feb 14, 2020

SELL
$20.54 - $31.0 $411,108 - $620,465
-20,015 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$22.78 - $40.58 $414,208 - $737,866
18,183 Added 992.52%
20,015 $456,000
Q2 2019

Aug 14, 2019

SELL
$16.03 - $31.1 $3,318 - $6,437
-207 Reduced 10.15%
1,832 $56,000
Q1 2019

May 10, 2019

BUY
$14.4 - $21.45 $14,558 - $21,685
1,011 Added 98.35%
2,039 $34,000
Q4 2018

Feb 13, 2019

SELL
$16.51 - $51.33 $1.22 Million - $3.8 Million
-74,048 Reduced 98.63%
1,028 $19,000
Q3 2018

Nov 13, 2018

BUY
$43.15 - $67.97 $915,513 - $1.44 Million
21,217 Added 39.39%
75,076 $3.93 Million
Q2 2018

Aug 10, 2018

BUY
$35.06 - $51.17 $1.89 Million - $2.76 Million
53,859 New
53,859 $2.34 Million

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.